Source: Annual Congress 2006 - Matrix remodelling at the interface of lung fibrosis and emphysema
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Labiris, K. Ask, T. Farncombe, R. Chirakal, M. Kolb (Hamilton, Canada). Molecular imaging of the progression of pulmonary fibrosis using animal models of disease. Eur Respir J 2006; 28: Suppl. 50, 3557

Member's Comments

No comment yet.

Related content which might interest you: 3he MRI and an animal model of interstitial lung disease Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities Year: 2009 Molecular mechanisms of lung tissue remodeling in progression of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD) Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Preclinical models and imaging biomarkers of lung injury and disease Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021 Use of PET/CT to evaluate pulmonary inflammation and fibrosis in an animal model Source: Eur Respir J 2006; 28: Suppl. 50, 606s Year: 2006 Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging Source: International Congress 2015 – New insights into IIPs Year: 2015 Morphologic evaluation of lung in a scleroderma-like rabbit model Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006 The pathogenesis of pulmonary fibrosis: a moving target Source: Eur Respir J 2013; 41: 1207-1218 Year: 2013 Novel imaging biomarkers for assessment of lung fibrosis and inflammation Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021 Tomographic pattern and disease progress or mortality in familial pulmonary fibrosis Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Endotrophin is related to disease progression in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Elucidating progression of early cystic fibrosis lung disease Source: Eur Respir J, 50 (5) 1701916; 10.1183/13993003.01916-2017 Year: 2017 Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019 Year: 2020 Imaging biomarkers of oedema and fibrosis in a rat model of Drug-Induced-ILD Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Prediction of survival in interstitial lung disease (ILD); role of DTPA lung clearance scans and lung function variables Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Non-invasive molecular imaging of pulmonary fibrosis Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018 A humanized animal model of pulmonary fibrosis based on cellular senescence Source: Virtual Congress 2020 – Cellular involvement in lung injury Year: 2020